Inari Medical to Present at the J.P. Morgan Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
BTIG Downgrades Inari Medical Inc. (NARI) to Neutral
January 7, 2025 4:09 PM ESTBTIG analyst Marie Thibault downgraded Inari Medical Inc. (NASDAQ: NARI) from Buy to Neutral.
The analyst comments "We are downgrading NARI shares to Neutral following the announcement on Monday, January 6 that Stryker (SYK, Buy, $394 PT; Analyst: Zimmerman) entered a definitive agreement to... More
Jefferies Downgrades Inari Medical Inc. (NARI) to Hold
January 7, 2025 11:49 AM ESTJefferies analyst Matthew Taylor downgraded Inari Medical Inc. (NASDAQ: NARI) from Buy to Hold with a price target of $80.00 (from $70.00).
The analyst comments "After the market close, SYK announced an agreement to acquire NARI for $80/shr in cash, equating to a fully... More
Stifel on Inari Medical Inc. (NARI): 'Quick Thoughts on the Deal and PEN Implications'
January 6, 2025 4:50 PM ESTStifel analyst Matthew Blackman reiterated a Hold rating and $50.00 price target on Inari Medical Inc. (NASDAQ: NARI)
The analyst comments "This afternoon, following a Reuters report noting that NARI is engaged with advisors evaluating potential interest from multiple parties, SYK formally announced a definitive agreement to acquire NARI for $80/share, or 6.5x 2025E revenues. Since we initiated on both NARI and PEN (here), we highlighted potential M&A in the mechanical thrombectomy (MT) space as highly likely, given the... More
